Pear Therapeutics (PEAR)

NASDAQ (Delisted)

Quick facts

TickerPEAR (NASDAQ (Delisted))

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: